Kim DS, Choi HI, Wang Y, Luo Y, Hoffer BJ, Greig NH (2017) A new treatment strategy for Parkinsons disease through the gut-brain axis: the glucagon-like peptide-1 receptor pathway
Ruff CT, Baron M, Im K, ODonoghue ML, Fiedorek FT, Sabatine MS (2022) Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial
Hemoglobin A1c levels typically rise within 3 months after discontinuation, and fasting and postprandial glucose levels increase as the medication's insulinotropic and glucagon-suppressing effects dissipate
Similar content being viewed by others Introduction Oxidative stress has been suggested as a possible etiology in a number of neurodegenerative diseases, including Alzheimers disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) 1
Understanding the likely side effects helps you prepare and distinguish normal adjustment from concerning symptoms
J Biol Chem 276: 30983105